190 related articles for article (PubMed ID: 32915926)
1. Extensive qPCR analysis reveals altered gene expression in middle ear mucosa from cholesteatoma patients.
Drakskog C; de Klerk N; Westerberg J; Mäki-Torkko E; Georén SK; Cardell LO
PLoS One; 2020; 15(9):e0239161. PubMed ID: 32915926
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in Toll-like receptors 2 and 4 genes and their expression in chronic suppurative otitis media.
Jotic A; Jesic S; Zivkovic M; Tomanovic N; Kuveljic J; Stankovic A
Auris Nasus Larynx; 2015 Dec; 42(6):431-7. PubMed ID: 26055429
[TBL] [Abstract][Full Text] [Related]
3. Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media.
Si Y; Zhang ZG; Chen SJ; Zheng YQ; Chen YB; Liu Y; Jiang H; Feng LQ; Huang X
Hum Immunol; 2014 Aug; 75(8):771-6. PubMed ID: 24882571
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Inflammatory and Homeostatic Roles of Tissue-resident Macrophages in the Progression of Cholesteatoma by RNA-Seq.
Fang L; Chen L; Lin B; Han L; Zhu K; Song Q
Immunol Invest; 2021 Aug; 50(6):609-621. PubMed ID: 32573304
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen in chronic otitis media: an immunohistochemical study of the middle ear mucosa.
Sankovic S; Sofronic L
Acta Otorhinolaryngol Belg; 2002; 56(1):61-4. PubMed ID: 11894632
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
[TBL] [Abstract][Full Text] [Related]
7. Expression of toll-like receptors 2, 4 and nuclear factor kappa B in mucosal lesions of human otitis: pattern and relationship in a clinical immunohistochemical study.
Jesic S; Jotic A; Tomanovic N; Zivkovic M
Ann Otol Rhinol Laryngol; 2014 Jun; 123(6):434-41. PubMed ID: 24690988
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
9. [Differential expression of toll-like receptors in chronic suppurative otitis media and cholesteatoma].
Si Y; Zhang ZG; Huang CY; He JF; Feng LQ; Chen YB; Chen T; Huang X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):388-93. PubMed ID: 22883581
[TBL] [Abstract][Full Text] [Related]
10. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
[TBL] [Abstract][Full Text] [Related]
11. The c-MYC protooncogene expression in cholesteatoma.
Palkó E; Póliska S; Csákányi Z; Katona G; Karosi T; Helfferich F; Penyige A; Sziklai I
Biomed Res Int; 2014; 2014():639896. PubMed ID: 24683550
[TBL] [Abstract][Full Text] [Related]
12. Expression of toll-like receptors in chronic otitis media and cholesteatoma.
Hirai H; Kariya S; Okano M; Fukushima K; Kataoka Y; Maeda Y; Nishizaki K
Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):674-6. PubMed ID: 23380629
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
Holly A; Sittinger M; Bujía J
Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression in cholesteatoma by DNA chip analysis.
Macias JD; Gerkin RD; Locke D; Macias MP
Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.
Szczepański M; Szyfter W; Jenek R; Wróbel M; Lisewska IM; Zeromski J
Eur Arch Otorhinolaryngol; 2006 Jul; 263(7):603-7. PubMed ID: 16538507
[TBL] [Abstract][Full Text] [Related]
16. Imaging guidance for cholesteatoma surgery using tissue autofluorescence.
Yang S; Farrell J; Ye S; Ahmad I; Valdez TA
J Biomed Opt; 2023 Jun; 28(6):066003. PubMed ID: 37334207
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
Holly A; Sittinger M; Bujia J
Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
[TBL] [Abstract][Full Text] [Related]
18. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
Ayache S; Tramier B; Strunski V
Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructure of the middle ear mucosa in patients with chronic otitus media with cholesteatoma.
Chao WY; Shen CL
Eur Arch Otorhinolaryngol; 1996; 253(1-2):56-61. PubMed ID: 8932432
[TBL] [Abstract][Full Text] [Related]
20. Association between human beta defensin expression and cholesteatoma formation.
Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
